Search Results - "HAND, S. L"

Granulocyte-macrophage colony-stimulating factor : An effective adjuvant for protein and peptide-based vaccines by DISIS, M. L, BERNHARD, H, SHIOTA, F. M, HAND, S. L, GRALOW, J. R, HUSEBY, E. S, GILLIS, S, CHEEVER, M. A

“…The current studies evaluate granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant. An important issue for developing vaccine therapy…”
Get full text

T cell receptor β-chain repertoires are nonrandomly selected in responses to HLA-DR1 by HAND, S. L, ALTER, M. D, FINN, O. J

“…T cell receptor (TCR) beta -chain usage by HLA-DR1 alloreactive T cell lines was examined to determine whether common TCR gene segments were used…”
Get full text

Peptide-based, but not whole protein, vaccines elicit immunity to HER- 2/neu, oncogenic self-protein by Disis, ML, Gralow, JR, Bernhard, H, Hand, SL, Rubin, WD, Cheever, MA

“…HER-2/neu, an overexpressed oncogenic protein, has been proposed as a human cancer vaccine target. HER-2/neu is a "self" protein, however, and methods of…”
Get full text

Immunity to oncogenic proteins by Cheever, M A, Disis, M L, Bernhard, H, Gralow, J R, Hand, S L, Huseby, E S, Qin, H L, Takahashi, M, Chen, W

Get more information

Dendritic Cells Lose Ability to Present Protein Antigen after Stimulating Antigen-Specific T Cell Responses, despite Upregulation of MHC Class II Expression by Bernhard, Helga, Huseby, Eric S., Hand, Susan L., Lohmann, Matthias, Batten, Wendy Y., Disis, Mary L., Gralow, Julie R., Büschenfelde, Karl-Hermann Meyer Zum, Öhlen, Claes, Cheever, Martin A.

“…Immature dendritic cells (DC) take up, process and present protein antigens; mature DC are specialized for stimulating primary T cell responses with increased…”
Get full text

T cell receptor V beta gene usage in HLA-DR1-reactive human T cell populations. The predominance of V beta 8 by Hand, S L, Hall, B L, Finn, O J

“…The functional specificity and T cell receptor (TCR) V beta gene expression of three class II HLA-DR1-reactive human T cell populations were examined. WP2, a…”
Get more information

Immunity to the HER-2/neu oncogenic protein by Disis, M L, Bernhard, H, Gralow, J R, Hand, S L, Emery, S R, Calenoff, E, Cheever, M A

“…The study of oncogenic viruses led to the discovery that transforming retroviruses contain oncogenes homologous with and/or derived from cellular…”
Get more information

In vitro priming to tumor-associated proteins by Hand, S L, Bernhard, H, Huseby, E S, Rubin, W D, Disis, M L, Cheever, M A

Get more information

T-cell receptor gene usage and expression in renal allograft-derived T-cell lines by Hand, S L, Hall, B L, Finn, O J

“…Southern blot analyses indicate that the T-cell receptors of alloreactive T-cell lines derived from needle biopsies of human kidney allografts are selected…”
Get more information

T cells receptor beta-chain repertoires are nonrandomly selected in responses to HLA-DR1 by Hand, S L, Alter, M D, Finn, O J

“…T cell receptor (TCR) beta-chain usage by HLA-DR1 alloreactive T cell lines was examined to determine whether common TCR gene segments were used…”
Get full text

Australian speech pathologists' views of what professional practices lead to successful outcomes of therapy by Adamson, B J, Hand, L S, Heard, R, Nordholm, L A

“…The relative importance attributed to factors perceived by speech pathologists as contributing to successful levels of therapeutic outcomes were addressed in a…”
Get more information

Variables affecting the T cell receptor V beta repertoire heterogeneity of T cells infiltrating human renal allografts by Hall, B L, Hand, S L, Alter, M D, Kirk, A D, Finn, O J

“…Donor-specific, alloreactive T cell lines may be grown from cells infiltrating human renal allografts. These T cell lines utilize restricted T cell receptor…”
Get more information

Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines by Disis, ML, Bernhard, H, Shiota, FM, Hand, SL, Gralow, JR, Huseby, ES, Gillis, S, Cheever, MA

“…The current studies evaluate granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant. An important issue for developing vaccine therapy…”
Get full text